Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Vaso-Occlusive Events Precipitated By Intraarticular Steroid Injections in Patients with Sickle Cell Disease

Landan Banks, Michel Gowhari, DO, Robert Molokie, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-142900

Published: 2020

Journal Articles

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Renee Cheng, MD, Andrew Srisuwananukorn, MD, Jin Han, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137272

Published: 2020

Journal Articles

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Renee Cheng, MD, Avani Singh, MD, Xu Zhang, PhD, Priyanka Nasa, Jin Han, Doris Alfaro, Laura Kavoliunaite, Chika Nwachukwu, CNP, Karen Woodard, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-137297

Published: 2020

Journal Articles

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Syeda Rahman, Andrew Srisuwananukorn, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Edith A. Nutescu, PharmD., MS, FCCP, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Jin Han

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-137166

Published: 2020

Journal Articles

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Jin Han, Andrew Srisuwananukorn, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Franklin Njoku, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-138753

Published: 2020

Journal Articles

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Mahir Khan, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Faiz Ahmed Hussain, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Victor R. Gordeuk, MD, Franklin Njoku, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139653

Published: 2020

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Renee Cheng, MD, Rishi Patel, MD, Sandra Kang, MD, Frances Tian, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Jayleen Patel, MD, Netanel Zilberstein, MD, Victor R Gordeuk, MD, Michel Gowhari, DO

Blood (2019) 134 (Supplement_1): 3396.

https://doi.org/10.1182/blood-2019-130877

Published: 2019

Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 2299.

https://doi.org/10.1182/blood-2019-128668

Published: 2019

Journal Articles

Managing Sickle Cell Disease Patients with Acute Pain Crisis in the Most Appropriate Setting

Michel Gowhari, DO, Tiesa Hughes-Dillard, Catherine Ryan, Alexia Johnson

Blood (2019) 134 (Supplement_1): 2169.

https://doi.org/10.1182/blood-2019-131102

Published: 2019

Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 9.

https://doi.org/10.1182/blood-2018-99-115128

Published: 2018

Journal Articles

Role of Automated Red Cell Exchange in Acute and Chronic Complications of Sickle Cell Disease

Shivi Jain, MD, Adam Rock, MD, Caitlin Lopes, Santosh L. Saraf, MD, Xu Zhang, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Sally Campbell-lee, MD

Blood (2018) 132 (Supplement 1): 3674.

https://doi.org/10.1182/blood-2018-99-115677

Published: 2018

Journal Articles

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Sandra Kang, MD, Rishi Patel, MD, Ali Kord Valeshabad, MD, Binal N. Shah, PhD, Rishabh Choudhari, Dallas De La Vara, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Karen Xie, MD, James P. Lash, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3663.

https://doi.org/10.1182/blood-2018-99-113637

Published: 2018

Journal Articles

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Adam Rock, MD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Rasha Raslan, MD, Michel Gowhari, DO, Shivi Jain, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2018-99-114820

Published: 2018

Journal Articles

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

Santosh L. Saraf, MD, Krishna Ghimire, MD, Pritesh Patel, MD, Karen Sweiss, PharmD, John G. Quigley, Irum Khan, MBBS, David Peace, MD, Michel Gowhari, DO, Shivi Jain, MD, John P. Galvin, MDMS,MPH, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2018) 132 (Supplement 1): 313.

https://doi.org/10.1182/blood-2018-99-113666

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2018-99-115508

Published: 2018

Journal Articles

HMOX1 and acute kidney injury in sickle cell anemia

Santosh L. Saraf, Maya Viner, Ariel Rischall, Rasha Raslan, Binal N. Shah, Xu Zhang, Jin Han, Michel Gowhari, Shivi Jain, Robert E. Molokie, Roberto F. Machado, James P. Lash, Victor R. Gordeuk

Blood (2018) 132 (15): 1621–1625.

https://doi.org/10.1182/blood-2018-05-853929

Published: 2018

Includes: Supplemental data

Journal Articles

The Abnormal Presence of Mitochondria in Circulating Red Blood Cells Cause an Increased Oxygen Consumption Rate, ROS Generation and Hemolysis in Patients with Sickle Cell Disease

Ramasamy Jagadeeswaran, PhD MSc, Hong Lenny, PhD, Benjamin Vazquez, BA, Joshua Muniz, BS, Aimee Schad, Shivi Jain, MD, Michel Gowhari, DO, Donald Lavelle, PhD, Alan Diamond, PhD, Robert E. Molokie, MD, Angela Rivers, MD PhD

Blood (2017) 130 (Supplement 1): 2237.

https://doi.org/10.1182/blood.V130.Suppl_1.2237.2237

Published: 2017

Journal Articles

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Jin Han, PharmD, PhD, Laura Kavoliunaite, APN, Santosh L. Saraf, MD, Shivi Jain, MD, Johara Hassan, MD, Lewis L Hsu, MD PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2017) 130 (Supplement 1): 4664.

https://doi.org/10.1182/blood.V130.Suppl_1.4664.4664

Published: 2017

NARROW

Vaso-Occlusive Events Precipitated By Intraarticular Steroid Injections in Patients with Sickle Cell Disease

Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Outcomes in Vaso-Occlusive Crisis Treatment in the Emergency Department Vs. Acute Care Observation Center

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Effects of Hydroxyurea and Renin-Angiotensin Blockade on Kidney Function in Sickle Cell Disease

Cancer Incidence and Chemotherapy Tolerance in Patients with Sickle Cell Disease

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Managing Sickle Cell Disease Patients with Acute Pain Crisis in the Most Appropriate Setting

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Role of Automated Red Cell Exchange in Acute and Chronic Complications of Sickle Cell Disease

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

HMOX1 and acute kidney injury in sickle cell anemia

The Abnormal Presence of Mitochondria in Circulating Red Blood Cells Cause an Increased Oxygen Consumption Rate, ROS Generation and Hemolysis in Patients with Sickle Cell Disease

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only